Published in Teach Learn Med on January 01, 2010
MD PhD programmes with relevance to imaging. Results from a European survey. Insights Imaging (2013) 0.85
The faculty costs to educate a biomedical sciences graduate student. CBE Life Sci Educ (2015) 0.75
Induction of cachexia in mice by systemically administered myostatin. Science (2002) 4.39
Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma. Cell (2010) 3.37
The influence of Hispanic ethnicity on nonsmall cell lung cancer histology and patient survival: an analysis of the Survival, Epidemiology, and End Results database. Cancer (2012) 3.12
Cancer care in the pediatric surgical patient: a paradigm to abolish volume-outcome disparities in surgery. Surgery (2008) 2.81
Lenalidomide monotherapy in relapsed or refractory aggressive non-Hodgkin's lymphoma. J Clin Oncol (2008) 2.80
Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes. J Biol Chem (2003) 2.67
Extranodal marginal zone lymphoma of the ocular adnexa. Blood (2009) 2.65
Inflammatory myofibroblastic tumors. J Surg Oncol (2006) 2.56
Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice. Diabetes (2003) 2.40
Differentiation stage-specific expression of microRNAs in B lymphocytes and diffuse large B-cell lymphomas. Blood (2008) 2.36
Oral and extraoral plasmablastic lymphoma: similarities and differences in clinicopathologic characteristics. Am J Clin Pathol (2010) 2.10
Lenalidomide oral monotherapy produces a high response rate in patients with relapsed or refractory mantle cell lymphoma. Br J Haematol (2009) 2.09
Expression of the human germinal center-associated lymphoma (HGAL) protein, a new marker of germinal center B-cell derivation. Blood (2005) 1.99
The oncoprotein LMO2 is expressed in normal germinal-center B cells and in human B-cell lymphomas. Blood (2006) 1.94
Current incidence and outcomes of gastrointestinal mesenchymal tumors including gastrointestinal stromal tumors. J Am Coll Surg (2006) 1.90
LMO2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy with and without rituximab. J Clin Oncol (2007) 1.88
Outcomes for soft-tissue sarcoma in 8249 cases from a large state cancer registry. J Surg Res (2007) 1.82
BCL6 gene translocation in follicular lymphoma: a harbinger of eventual transformation to diffuse aggressive lymphoma. Blood (2003) 1.73
Chondrosarcoma in the United States (1973 to 2003): an analysis of 2890 cases from the SEER database. J Bone Joint Surg Am (2009) 1.71
The t(14;18) defines a unique subset of diffuse large B-cell lymphoma with a germinal center B-cell gene expression profile. Blood (2002) 1.68
Primary bone lymphoma--the University of Miami experience. Leuk Lymphoma (2010) 1.68
Lethal injection for execution: chemical asphyxiation? PLoS Med (2007) 1.63
STAT3 activation in skeletal muscle links muscle wasting and the acute phase response in cancer cachexia. PLoS One (2011) 1.61
Pediatric thyroid carcinoma: incidence and outcomes in 1753 patients. J Surg Res (2009) 1.61
Impact of teaching facility status and high-volume centers on outcomes for lung cancer resection: an examination of 13,469 surgical patients. Ann Surg Oncol (2008) 1.60
Ofatumumab in combination with ICE or DHAP chemotherapy in relapsed or refractory intermediate grade B-cell lymphoma. Blood (2013) 1.60
African American and poor patients have a dramatically worse prognosis for head and neck cancer: an examination of 20,915 patients. Cancer (2008) 1.57
Disparities in survival among women with invasive cervical cancer: a problem of access to care. Cancer (2009) 1.56
JAK/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia. Am J Physiol Endocrinol Metab (2012) 1.56
Paraffin-based 6-gene model predicts outcome in diffuse large B-cell lymphoma patients treated with R-CHOP. Blood (2008) 1.55
Retroperitoneal and truncal sarcomas: prognosis depends upon type not location. Ann Surg Oncol (2007) 1.55
Defining the role of surgery for primary gastrointestinal tract melanoma. J Gastrointest Surg (2007) 1.55
Frequency and extent of CD30 expression in diffuse large B-cell lymphoma and its relation to clinical and biologic factors: a retrospective study of 167 cases. Leuk Lymphoma (2013) 1.52
Defining treatment and outcomes of hepaticojejunostomy failure following pancreaticoduodenectomy. J Gastrointest Surg (2013) 1.51
Does surgery or radiation therapy impact survival for patients with extrapulmonary small cell cancers? J Surg Oncol (2011) 1.50
Are many community hospitals undertreating breast cancer?: lessons from 24,834 patients. Ann Surg (2008) 1.50
Paradoxical effects of short- and long-term interleukin-6 exposure on liver injury and repair. Hepatology (2006) 1.49
Should soft tissue sarcomas be treated at high-volume centers? An analysis of 4205 patients. Ann Surg (2007) 1.48
Expression profiles of adult T-cell leukemia-lymphoma and associations with clinical responses to zidovudine and interferon alpha. Leuk Lymphoma (2010) 1.46
Acute inhibition of myostatin-family proteins preserves skeletal muscle in mouse models of cancer cachexia. Biochem Biophys Res Commun (2009) 1.45
Does chemoradiotherapy improve outcomes for surgically resected adenocarcinoma of the stomach or esophagus? Ann Surg Oncol (2009) 1.44
[18F]-fluorodeoxyglucose positron emission tomography combined with computed tomography detection of asymptomatic late pulmonary toxicity in patients with non-Hodgkin lymphoma treated with rituximab-containing chemotherapy. Leuk Lymphoma (2009) 1.44
Prediction of survival in diffuse large B-cell lymphoma based on the expression of 2 genes reflecting tumor and microenvironment. Blood (2011) 1.41
Association between non-Hodgkin lymphoma and renal cell carcinoma. Leuk Lymphoma (2011) 1.41
Primary lymphoma of bone in adult patients. Cancer (2010) 1.41
Pediatric intestinal foregut and small bowel solid tumors: a review of 105 cases. J Surg Res (2009) 1.40
Transformation of follicular lymphoma to diffuse large cell lymphoma is associated with a heterogeneous set of DNA copy number and gene expression alterations. Blood (2002) 1.40
The Drivers of Academic Success in Cleft and Craniofacial Centers: A 10-Year Analysis of over 2000 Publications. Plast Reconstr Surg (2017) 1.40
Survival effects of adjuvant chemoradiotherapy after resection for pancreatic carcinoma. Arch Surg (2010) 1.39
Ewing sarcoma demonstrates racial disparities in incidence-related and sex-related differences in outcome: an analysis of 1631 cases from the SEER database, 1973-2005. Cancer (2009) 1.38
Ocular adnexal lymphoma: a clinicopathologic study of a large cohort of patients with no evidence for an association with Chlamydia psittaci. Blood (2005) 1.38
PTP1B is a negative regulator of interleukin 4-induced STAT6 signaling. Blood (2008) 1.32
Growth differentiation factor-15/macrophage inhibitory cytokine-1 induction after kidney and lung injury. Shock (2005) 1.31
Do racial or socioeconomic disparities exist in lung cancer treatment? Cancer (2010) 1.25
Interleukin-6 inhibits cell proliferation in a rat model of hepatocellular carcinoma. Liver Int (2005) 1.23
Malignant pancreatic tumors: incidence and outcome in 58 pediatric patients. J Pediatr Surg (2009) 1.21
Interleukin-6 inhibits oxidative injury and necrosis after extreme liver resection. Hepatology (2007) 1.20
T-cell protein tyrosine phosphatase, distinctively expressed in activated-B-cell-like diffuse large B-cell lymphomas, is the nuclear phosphatase of STAT6. Mol Cell Biol (2007) 1.20
Massive liver growth in mice induced by systemic interleukin 6 administration. Hepatology (2003) 1.19
Decreased aquaporin expression leads to increased resistance to apoptosis in hepatocellular carcinoma. Cancer Lett (2006) 1.19
Expression of MALT1 oncogene in hematopoietic stem/progenitor cells recapitulates the pathogenesis of human lymphoma in mice. Proc Natl Acad Sci U S A (2012) 1.19
Optimization of RNA extraction from formalin-fixed, paraffin-embedded lymphoid tissues. Diagn Mol Pathol (2007) 1.17
MicroRNAs are independent predictors of outcome in diffuse large B-cell lymphoma patients treated with R-CHOP. Clin Cancer Res (2011) 1.17
Interleukin-6 is an important in vivo inhibitor of intestinal epithelial cell death in mice. Gut (2008) 1.16
Prognostic significance of VEGF, VEGF receptors, and microvessel density in diffuse large B cell lymphoma treated with anthracycline-based chemotherapy. Lab Invest (2007) 1.16
Detecting blunt pancreatic injuries. J Gastrointest Surg (2002) 1.16
Molecular pathogenesis of hepatocellular carcinoma. J Surg Res (2006) 1.15
Outcomes of malignant CNS ependymomas: an examination of 2408 cases through the Surveillance, Epidemiology, and End Results (SEER) database (1973-2005). J Surg Res (2009) 1.14
Rhabdomyosarcoma in children: a SEER population based study. J Surg Res (2011) 1.13
A novel molecular mechanism involved in multiple myeloma development revealed by targeting MafB to haematopoietic progenitors. EMBO J (2012) 1.12
Results of 23,810 cases of ductal carcinoma-in-situ. Ann Surg Oncol (2007) 1.10
Malignant abdominal mesothelioma: defining the role of surgery. J Surg Oncol (2009) 1.09
The roles of neoadjuvant radiotherapy and lymphadenectomy in the treatment of esophageal adenocarcinoma. Ann Surg Oncol (2009) 1.09
HGAL, a lymphoma prognostic biomarker, interacts with the cytoskeleton and mediates the effects of IL-6 on cell migration. Blood (2007) 1.08
Rapid establishment of dendritic cell chimerism in allogeneic hematopoietic cell transplant recipients. Blood (2002) 1.07
Novel IL-21 signaling pathway up-regulates c-Myc and induces apoptosis of diffuse large B-cell lymphomas. Blood (2009) 1.07
Body surface area prediction in normal, hypermuscular, and obese mice. J Surg Res (2008) 1.07
IRF-4 and c-Rel expression in antiviral-resistant adult T-cell leukemia/lymphoma. Blood (2007) 1.06
Pediatric non-Wilms renal tumors: subtypes, survival, and prognostic indicators. J Surg Res (2010) 1.06
Obesity and weight loss at presentation of lung cancer are associated with opposite effects on survival. J Surg Res (2011) 1.06
Hepatectomy enables prolonged survival in select patients with isolated noncolorectal liver metastasis. J Am Coll Surg (2006) 1.04
Osteosarcoma: improvement in survival limited to high-grade patients only. J Cancer Res Clin Oncol (2010) 1.03
Interleukin-6 mediates G(0)/G(1) growth arrest in hepatocellular carcinoma through a STAT 3-dependent pathway. J Surg Res (2007) 1.03
CD30 targeting with brentuximab vedotin: a novel therapeutic approach to primary effusion lymphoma. Blood (2013) 1.02
Primary diffuse large cell lymphoma of the mandible. Leuk Lymphoma (2004) 1.01
Cryoablation of unresectable pancreatic cancer. Surgery (2002) 1.01
Thrombophilic state in cancer, part I: biology, incidence, and risk factors. J Surg Oncol (2011) 1.01
Scientific impact of women in academic surgery. J Surg Res (2008) 1.00
Effect of in vivo loss of GDF-15 on hepatocellular carcinogenesis. J Cancer Res Clin Oncol (2008) 1.00
Markedly improving survival of neuroblastoma: a 30-year analysis of 1,646 patients. Pediatr Surg Int (2007) 0.99
Surgery does not adversely affect survival in primary gastrointestinal lymphoma. J Surg Oncol (2009) 0.99
Insulin-like growth factor I is a comitogen for hepatocyte growth factor in a rat model of hepatocellular carcinoma. Hepatology (2002) 0.99
Central nervous system manifestations of marginal zone B-cell lymphoma. Ann Hematol (2010) 0.98
Germinal centre protein HGAL promotes lymphoid hyperplasia and amyloidosis via BCR-mediated Syk activation. Nat Commun (2013) 0.98
Efficacy of bortezomib in a direct xenograft model of primary effusion lymphoma. Proc Natl Acad Sci U S A (2010) 0.98
Pediatric solid tumors and second malignancies: characteristics and survival outcomes. J Surg Res (2009) 0.98
Peritoneal drainage versus laparotomy for necrotizing enterocolitis and intestinal perforation: a meta-analysis. J Surg Res (2009) 0.97
7201 carcinoids: increasing incidence overall and disproportionate mortality in the elderly. World J Surg (2007) 0.97